Groups | P-Values | ||||||
---|---|---|---|---|---|---|---|
Variable | C9Plus | C9Minus | Control | Groupsa | C9Plus vs C9Minusb | C9Plus vs Controlb | C9Minus vs Controlb |
Methylation, median (IQR), % | 4.05 (1.10–17.95) | 0.24 (0.15–0.33) | 0.46 (0.14–0.75) | 4.45e-15 | 1.70e-13 | 3.33e-07 | 0.17 |
Total, median (IQR), % | 73.32 (65.96–86.20) | 110.70 (93.68–132.88) | 100.00 (87.48–111.27) | 2.06e-07 | 3.67e-07 | 9.08e-05 | 0.13 |
Variant 1, median (IQR), % | 55.66 (48.14–72.82) | 80.10 (70.31–94.64) | 100.00 (74.87–110.67) | 1.07e-05 | 2.83e-04 | 3.65e-05 | 0.06 |
Variant 2, median (IQR), % | 61.97 (55.23–73.67) | 104.75 (85.86–139.38) | 100.00 (90.04–120.12) | 9.66e-08 | 3.43e-07 | 1.10e-05 | 0.76 |
Intron 1a, median (IQR), % | 411.20 (244.09–637.62) | 263.06 (103.15–398.10) | 100.00 (37.09–290.55) | 8.40e-04 | 0.01 | 4.03e-04 | 0.13 |
Intron 1b, median (IQR), % | 61.18 (54.37–90.30) | 98.61 (75.58–109.73) | 100.00 (67.11–130.03) | 0.003 | 0.002 | 0.01 | 0.48 |